Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Registration Study of Infusion-related Adverse Events at Administration of Mabthera (Rituximab) in the Treatment of Chronic Lymphocytic Leukemia.

NCT01072240 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01072240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01072240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Registration Study of Infusion-related Adverse Events at Administration of Mabthera (Rituximab) in the Treatment of Chronic Lymphocytic Leukemia.
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
June 30, 2011
Enrollment
92 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

lymphocytic leukemia, chronic